Healthy Skepticism Library item: 7263

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Cuatrecasas P.
Drug discovery in jeopardy.
J Clin Invest 2006 Nov; 116:(11):2837-42
http://www.jci.org/cgi/content/full/116/11/2837

Abstract:

Despite striking advances in the biomedical sciences, the flow of new drugs has slowed to a trickle, impairing therapeutic advances as well as the commercial success of drug companies. Reduced productivity in the drug industry is caused mainly by corporate policies that discourage innovation. This is compounded by various consequences of mega-mergers, the obsession for blockbuster drugs, the shift of control of research from scientists to marketers, the need for fast sales growth, and the discontinuation of development compounds for nontechnical reasons. Lessons from the past indicate that these problems can be overcome, and herein, new and improved directions for drug discovery are suggested.

Keywords:
Drug Design* Drug Industry/economics Drug Industry/history Drug Industry/trends* History, 20th Century History, 21st Century Humans United States United States Food and Drug Administration